Reproductive Health

A major study has shown that pregnant individuals treated with buprenorphine for opioid use disorder have lower risks of severe complications, preterm birth, and NICU admissions.

A new study reveals a potential link between certain hormonal IUDs and the onset of rosacea, with dermatologists urging awareness of symptoms and treatment options.

After 25 years of pioneering research, the UK celebrates its first birth following a womb transplant, offering new hope to women without a functioning uterus.

Research presented at ESCMID Global 2025 reveals how Schistosoma haematobium infection and praziquantel treatment may trigger gene activity linked to cervical cancer risk in women.

Interleukin-6 may outperform traditional tests like CRP and procalcitonin for diagnosing sepsis earlier in vulnerable populations, offering hope for more timely, targeted care.

A new case report documents the first live birth following fertilization by a fully automated, remotely operated intracytoplasmic sperm injection (ICSI) system, showcasing a breakthrough in assisted reproductive technology.

New research links the severity of menopausal symptoms to cognitive decline and mild behavioural impairment in later life, with hormone therapy showing potential protective effects.

A large cohort study from Sweden reveals that men with sisters diagnosed with polycystic ovary syndrome (PCOS) face elevated cardiometabolic risks as early as adolescence.